Your browser doesn't support javascript.
loading
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case Report.
Blasi, Miriam; Kazdal, Daniel; Thomas, Michael; Christopoulos, Petros; Kriegsmann, Mark; Brandt, Regine; Volckmar, Anna-Lena; Kirchner, Martina; Heußel, Claus Peter; Stenzinger, Albrecht; Kuon, Jonas.
Afiliación
  • Blasi M; Department of Thoracic Oncology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.
  • Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Thomas M; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Christopoulos P; Department of Thoracic Oncology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.
  • Kriegsmann M; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Brandt R; Department of Thoracic Oncology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.
  • Volckmar AL; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Kirchner M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Heußel CP; Translational Lung Research Center (TLRC) Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.
  • Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Kuon J; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Case Rep Oncol ; 14(1): 477-482, 2021.
Article en En | MEDLINE | ID: mdl-33976623

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Oncol Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Oncol Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza